Blood Coagulation Testing Market

혈액 응고 테스트 시장 조사 보고서 – 2032년까지 예측

Forecast Period
2025 - 2035
CAGR
6.31%
2024 Market Size
$ 4.81 Billion
2035 Market Size
$ 9.43 Billion
Life Sciences ● Updated July 20, 2026 Report ID: MRFR/LS/0464-CR | Pages: 128 | Author: Nidhi Mandole, Rahul Gotadki

Blood Coagulation Testing Market 요약

Our Impact

Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals

Partnering with 2000+ Global Organizations Each Year

30K+ Citations by Top-Tier Firms in the Industry

Blood Coagulation Testing Market 시장의 주요 기업은 다음과 같습니다

향후 전망

Blood Coagulation Testing Market 향후 전망

보고서 범위

시장 하이라이트

FAQs

What is the projected market valuation of the Blood Coagulation Testing Market by 2035?

The Blood Coagulation Testing Market is projected to reach approximately 9.431 USD Billion by 2035.

What was the market valuation of the Blood Coagulation Testing Market in 2024?

In 2024, the Blood Coagulation Testing Market was valued at 4.81 USD Billion.

What is the expected CAGR for the Blood Coagulation Testing Market during the forecast period 2025 - 2035?

The expected CAGR for the Blood Coagulation Testing Market during the forecast period 2025 - 2035 is 6.31%.

Which companies are considered key players in the Blood Coagulation Testing Market?

Key players in the Blood Coagulation Testing Market include Roche Diagnostics, Siemens Healthineers, Abbott Laboratories, and Thermo Fisher Scientific.

What are the main product segments in the Blood Coagulation Testing Market?

The main product segments in the Blood Coagulation Testing Market are Consumables, valued at 5.66 USD Billion, and Instruments, valued at 3.77 USD Billion.

How do acquired and inherited bleeding disorders compare in market valuation?

Acquired bleeding disorders are projected to reach 4.8 USD Billion, while inherited bleeding disorders are expected to reach 4.63 USD Billion by 2035.

What is the market size for Prothrombin Time Testing by 2035?
Prothrombin Time Testing is projected to reach a market size of 2.4 USD Billion by 2035.
Which end-user segment is expected to dominate the Blood Coagulation Testing Market?
Hospitals and Clinics are expected to dominate the Blood Coagulation Testing Market, with a projected valuation of 2.88 USD Billion by 2035.
What is the anticipated growth for Activated Partial Thromboplastin Time (aPTT) Testing by 2035?
Activated Partial Thromboplastin Time (aPTT) Testing is anticipated to grow to a market size of 2.0 USD Billion by 2035.
How does the market for diagnostic centers compare to ambulatory care centers in 2035?
By 2035, the market for diagnostic centers is projected to reach 2.4 USD Billion, while ambulatory care centers are expected to reach 2.26 USD Billion.

저자
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
공유:
무료 샘플 요청
무료 샘플 다운로드

이 보고서의 무료 샘플을 받으려면 아래 양식을 작성하십시오

공유:
무료 샘플 요청
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.